Meihua Chen

Dr. Meihua Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
JHJunlin He
Junlin He
YLYefei Liu
Yefei Liu
HXHongzhen Xu
Hongzhen Xu
XWXiaoling Wei
Xiaoling Wei
MCMeihua Chen
Meihua Chen

21 November 2024 in ACS Central Science
Verified
Journal Article
Open access
JLJichun Li
Jichun Li
LXLingxiao Xue
Lingxiao Xue
YDYu Deng
Yu Deng
XCXiaowei Cheng
Xiaowei Cheng
JMJunhao Ma
Junhao Ma
YDYonghui Deng
Yonghui Deng
An efficient regiospecific co-assembly (RSCA) strategy is developed for general synthesis of mesoporous metal oxides with pore walls precisely decorated by highly dispersed noble metal nanocrystals with customized parameters (diameter and composition). It features the rational utilization of the specific interactions between hydrophilic molecular precursors, hydrophobic noble metal nanocrystals, and amphiphilic block copolymers, to achieve regiospecific co-assembly as confirmed by molecular dynamics simulations. Through this RSCA strategy, we achieved a controllable synthesis of a variety of functional mesoporous metal oxide composites (e.g., WO3, ZrO2, TiO2) with in-pore walls precisely decorated by various noble metal nanocrystals of tailored components (Au, Ag, Pt, Pd and their nanoalloys) and sizes (3.0-8.5 nm). As an example, the obtained mesoporous 0.5-Ag/WO3 material has a highly interconnected mesoporous structure and uniform 6.5 nm Ag nanocrystals confined in the mesopores, showing superior NO sensing performances with high sensitivity, good selectivity, and stability at low working temperature (127 °C). In situ spectroscopy study indicates that the NO sensing process involves a unique gas-solid reaction, where NO molecules are converted into chemisorbed NO x species over the sensitive materials, inducing a remarkable change of resistance and outputting a dramatic response signal.

17 November 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
YCYan Chen
Yan Chen
NJNing Jiang
Ning Jiang
MCMeihua Chen
Meihua Chen
BSBaiyan Sui
Baiyan Sui
Xin LiuXin Liu
Xin Liu
The mRNA vaccines have been considered effective for combating cancer. However, the core components of the mRNA vaccines against head and neck squamous cell carcinoma (HNSCC) and the effects remain unclear. Our study aims to identify effective antigens in HNSCC to develop mRNA vaccines for corresponding potential patients. Here, we analyzed alternative splicing and mutation of genes in TCGA-HNSCC samples and identified seven potential tumor antigens, including SREBF1, LUC7L3, LAMA5, PCGF3, HNRNPH1, KLC4, and OFD1, which were associated with nonsense-mediated mRNA decay factor expression, overall survival prognosis and the infiltration of antigen-presenting cells. Furthermore, to select suitable patients for vaccination, immune subtypes related to HNSCC were identified by consensus clustering analysis, and visualization of the HNSCC immune landscape was performed by graph-learning-based dimensionality reduction. To address the heterogeneity of the population that is suitable for vaccination, plot cell trajectory and WGCNA were also utilized. HNSCC patients were classified into three prognostically relevant immune subtypes (Cluster 1, Cluster 2, and Cluster 3) possessing different molecular and cellular characteristics, immune modulators, and mutation statuses. Cluster 1 had an immune-activated phenotype and was associated with better survival, while Cluster 2 and Cluster 3 were immunologically cold and linked to increased tumor mutation burden. Therefore, HNSCC patients with immune subtypes Cluster 2 and Cluster 3 are potentially suitable for mRNA vaccination. Moreover, the prognostic module hub genes screened seven genes, including IGKC, IGHV3-15, IGLV1-40, IGLV1-51, IGLC3, IGLC2, and CD79A, which could be potential biomarkers to predict prognosis and identify suitable patients for mRNA vaccines. Our findings provide a theoretical basis for further research and the development of anti-HNSCC mRNA vaccines and the selection of suitable patients for vaccination.

12 February 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
TBTianying Bian
Tianying Bian
HLHu Li
Hu Li
HLHaohao Liu
Haohao Liu
MGMudi Guo
Mudi Guo
YZYiding Zhang
Yiding Zhang
MCMeihua Chen
Meihua Chen

1 January 2024 in Stem Cells International
Verified
Journal Article
Open access
MZMeng-Han Zhang
Meng-Han Zhang
LYLi-Ming Yu
Li-Ming Yu
WZWei-Hua Zhang
Wei-Hua Zhang
JDJia-Jia Deng
Jia-Jia Deng
BSBing-Jing Sun
Bing-Jing Sun
YLYuehua liu
Yuehua liu
A proper source of stem cells is key to muscle injury repair. Dental pulp stem cells (DPSCs) are an ideal source for the treatment of muscle injuries due to their high proliferative and differentiation capacities. However, the current myogenic induction efficiency of human DPSCs hinders their use in muscle regeneration due to the unknown induction mechanism. In this study, we treated human DPSCs with Noggin, a secreted antagonist of bone morphogenetic protein (BMP), and discovered that Noggin can effectively promote myotube formation. We also found that Noggin can accelerate the skeletal myogenic differentiation (MyoD) of DPSCs and promote the generation of Pax7+ satellite‐like cells. Noggin increased the expression of myogenic markers and the transcriptional and translational abundance of satellite cell (SC) markers in DPSCs. Moreover, BMP4 inhibited Pax7 expression and activated p‐Smad1/5/9, while Noggin eliminated BMP4‐induced p‐Smad1/5/9 in DPSCs. This finding suggests that Noggin antagonizes BMP by downregulating p‐Smad and facilitates the MyoD of DPSCs. Then, we implanted Noggin‐pretreated DPSCs combined with Matrigel into the mouse tibialis anterior muscle with volumetric muscle loss (VML) and observed a 73% reduction in the size of the defect and a 69% decrease in scar tissue. Noggin‐treated DPSCs can benefit the Pax7+ SC pool and promote muscle regeneration. This work reveals that Noggin can enhance the production of satellite‐like cells from the MyoD of DPSCs by regulating BMP/Smad signaling, and these satellite‐like cell bioconstructs might possess a relatively fast capacity for muscle regeneration.

23 September 2025 in Journal of Dentistry
Verified
Journal Article
Closed access
JHJunlin He
Junlin He
MCMeihua Chen
Meihua Chen
HLHaohao Liu
Haohao Liu
HLHui Liu
Hui Liu
MXMi Xu
Mi Xu
MCMeihua Chen
Meihua Chen